Thermogenesis Holdings Inc THMO:NASDAQ

RT Quote | NASDAQ | USD
Last | 02/26/21 EST
2.85quote price arrow down-0.26 (-8.36%)
Volume
913,887
52 week range
1.63 - 14.18

...

Loading . . .

KEY STATS

  • Open3.03
  • Day High3.09
  • Day Low2.65
  • Prev Close2.85
  • 52 Week High14.18
  • 52 Week High Date04/30/20
  • 52 Week Low1.63
  • 52 Week Low Date03/18/20
  • Market Cap22.23M
  • Shares Out7.80M
  • 10 Day Average Volume0.92M
  • Dividend-
  • Dividend Yield-
  • Beta3.28
  • 1 Year % Change-30.15

RATIOS/PROFITABILITY

  • EPS (TTM)-3.78
  • P/E (TTM)-0.75
  • Fwd P/E (NTM)-7.50
  • EBITDA (MRQ)-9.946M
  • ROE (MRQ)-496.01%
  • Revenue (MRQ)9.52M
  • Gross Margin (MRQ)10.11%
  • Net Margin (MRQ)-189.79%
  • Debt To Equity (MRQ)196.84%

EVENTS

  • Earnings Date03/25/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Thermogenesis Holdings Inc News

There is no recent news for this security.

Latest THMO News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
ThermoGenesis Holdings, Inc., formerly Cesca Therapeutics Inc., develops, commercializes and markets a range of automated technologies for chimeric antigen receptor (CAR)-T and other cell-based therapies. It offers a suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology. Its CAR-TXpress platform is its cellular processing platform. It offers cell manufacturing tools and services in the global cell and gene therapy...
Xiaochun Xu Ph.D.
Chairman
Jeffery Cauble CPA
Chief Financial Officer
Address
2711 Citrus Rd
Rancho Cordova, CA
95742-6228
United States